Aquestive Therapeutics (AQST) Intangibles (2017 - 2024)

Aquestive Therapeutics' Intangibles history runs 8 years deep, the most recent figure standing at $1.2 million for Q1 2024.

• On a quarterly basis, Intangibles fell 11.25% year-over-year to $1.2 million in Q1 2024; TTM through Mar 2024 was $1.2 million, a 11.25% decrease from a year earlier, with the FY2023 full-year figure at $1.3 million, down 10.94% from the prior year.
• Intangibles fell to $1.2 million in Q1 2024 per AQST's latest filing, from $1.3 million in the prior quarter.
• Across five years, Intangibles topped out at $2.9 million in Q1 2021 and bottomed at $25000.0 in Q2 2022.
• The 5-year median for Intangibles is $140000.0 (2020), against an average of $771411.8.
• Across the five-year window, Intangibles tumbled 98.67% in 2022 and soared 5328.0% in 2023, its largest moves.
• Year by year, Intangibles stood at $102000.0 in 2020, then sank by 50.0% to $51000.0 in 2021, then surged by 2713.73% to $1.4 million in 2022, then slipped by 10.94% to $1.3 million in 2023, then slipped by 3.05% to $1.2 million in 2024.
• Per Business Quant, the three latest AQST Intangibles figures stand at $1.2 million (Q1 2024), $1.3 million (Q4 2023), and $1.3 million (Q3 2023).